FDA label
What is Tezspire used for?
Tezspire contains tezepelumab. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Tezspire lists 2 uses: Asthma; Chronic Rhinosinusitis with Nasal Polyps.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Tezspire?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Tezspire, injection, solution
Indications and Usage, quoted from the label by Amgen Inc (BLA761224). Cross-references to other label sections are left out.
Asthma
TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.
Limitations of Use:
TEZSPIRE is not indicated for the relief of acute bronchospasm or status asthmaticus.
Chronic Rhinosinusitis with Nasal Polyps
TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP).
Source: DailyMed label, set id 60f0aa03-ad25-4d48-80ce-7fcfa76f325f, version 16, effective October 17, 2025. NDC 55513-112, one of 2 listings for this product.
Questions
What is Tezspire used for?
The FDA label for Tezspire lists 2 uses: Asthma; Chronic Rhinosinusitis with Nasal Polyps.
What drug class is Tezspire?
FDA lists tezepelumab in the Thymic Stromal Lymphopoietin Blocker established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.